EEG abnormality as a prognostic factor in cirrhotic patients with Grade III-IV hepatic encephalopathy requiring mechanical ventilation: A retrospective analysis
Background & aim: Hepatic encephalopathy is a serious complication that entails liver cirrhosis with a high mortality rate. The Child- Turcotte-Pugh class (CTP class) and model for end-stage liver disease (MELD) score are two important prognostic indicators for cirrhosis, while sequential organ failure assessment (SOFA) is a dynamic score for the assessment of critically ill patients. Patients with liver disease with advanced CTP class and higher MELD scores have poor prognosis. The aim of this study was to evaluate the role of electroencephalography (EEG) in cirrhotic patients requiring ventilator support for hepatic encephalopathy grade III-IV.
Methods: A retrospective study was conducted on patients admitted to the liver intensive care unit (ICU) of a tertiary teaching institute. EEG records of 92 patients with grade III-IV hepatic encephalopathy who were admitted between April 2015 and May 2017 to the liver ICU were analysed. The correlation between EEG findings and 28-day mortality, ICU length of stay, and the number of days on mechanical ventilation was determined.
Results: Seventy-eight of 92 patients (85%) exhibited bilateral slowing EEG pattern, suggestive of encephalopathy. A triphasic pattern was the most common EEG abnormality in 40% (31 of 78) of the patients. Patients with abnormal EEG had a significantly higher MELD score compared to those with a normal EEG (p=0.02). There were no significant differences in length of mechanical ventilation between both groups, but an increasing trend was observed in those with abnormal EEG (p=0.09).
Conclusion: EEG findings correlate well with severity of disease in critically ill patients with liver disease.
Relevance for Patients: EEG has a role in monitoring and prognostication of hepatic encephalopathy in critically ill patients with liver disease.
[1] Rothstein JD, Herlong HF. Neurologic Manifestations of Hepatic Disease. Neurol Clin 1989;7:563-78.
[2] D’Amico G, Garcia-Tsao G, Pagliaro L. Natural History and Prognostic Indicators of Survival in Cirrhosis: ASystematic Review of 118 Studies. J Hepatol 2006;44:217-31.
[3] Romero-Gomez M, Montagnese S, Jalan R. Hepatic Encephalopathy in Patients with Acute Decompensation of Cirrhosis and Acute-on-chronic Liver Failure. J Hepatol 2015;62:437-47.
[4] Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic Encephalopathy as a Predictor of Survival in Patients with End-Stage Liver Disease. Liver Transpl 2007;13:1366-71.
[5] Cordoba, J, Ventura-Cots, M, Simon-Talero, M. Characteristics, Risk Factors, and Mortality of Cirrhotic Patients Hospitalized for Hepatic Encephalopathy with and Without Acute-on-Chronic Liver Failure (ACLF). J Hepatol 2014;60:275-81.
[6] Kaplan PW, Rossetti AO. EEG Patterns and Imaging Correlations in Encephalopathy: Encephalopathy Part II. J Clin Neurophysiol 2011;28:233-51.
[7] Foley JM, Watson CW, Adams RD. Significance of the Electroencephalographic Changes in Hepatic Coma. Trans Am Neurol Assoc 1950;51:161-5.
[8] Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 2014;60:715-35.
[9] Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological and Neuropsychological Tests for the Diagnosis of Subclinical Hepatic Encephalopathy and Prediction of Overt Encephalopathy. Liver 2002;22:190-7.
[10] Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The Prognostic Significance of Subclinical Hepatic Encephalopathy. Am J Gastroenterol 2000;95:2029-34.
[11] Koziarska D, Wunsch E, Milkiewicz M, Wojcicki M, Nowacki P. Milkiewicz Mini-Mental State Examination in Patients with Hepatic Encephalopathy and Liver Cirrhosis: A Prospective, Quantified Electroencephalography Study. BMC Gastroenterol 2013;13:107.
[12] Parsons-Smith BG, Summerskill WH, Dawson AM, Sherlock S. The Electroencephalograph in Liver Disease. Lancet 1957;273:867-71.
[13] Montagnese S, Amodio P, Morgan MY. Methods for Diagnosing Hepatic Encephalopathy in Patients with Cirrhosis: A Multidimensional Approach. Metab Brain Dis 2004;19:281-312.
[14] van der Rijt CC, Schalm SW. Quantitative EEG Analysis and Survival in Liver Disease. Electroencephalogr Clin Neurophysiol 1985;61:502-4.
[15] Bajaj JS, O’Leary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, et al. Hepatic Encephalopathy is Associated with Mortality in Patients with Cirrhosis Independent of Other Extrahepatic Organ Failures. Clin Gastroenterol Hepatol 2017;15:565-74.e4.
[16] Marchetti P, D’Avanzo C, Orsato R, Montagnese S, Schiff S, Kaplan PW, et al. Electroencephalography in Patients with Cirrhosis. Gastroenterology 2011;141:1680-9.
[17] Bickford RG, Butt HR. Hepatic coma: The Electroencephalographic Pattern. J Clin Invest 1955;34:790-9. [18] Brenner RP. The Interpretation of the EEG in Stupor and Coma. Neurologist 2005;11:271-84.
[19] Kaplan PW. The EEG in Metabolic Encephalopathy and Coma. J Clin Neurophysiol 2004;21:307-18.
[20] Sundaram MB, Blume WT. Triphasic Waves: Clinical Correlates and Morphology. Can J Neurol Sci 1987;14: 136-40.
[21] Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, Wells GA. The Encephalopathy Associated with Septic Illness. Clin Invest Med 1990;13:297-304.
[22] Ficker DM, Westmoreland BF, Sharbrough FW. Epileptiform Abnormalities in Hepatic Encephalopathy. J Clin Neurophysiol 1997;14:230-4.
[23] Tanaka H, Ueda H, Kida Y, Hamagami H, Tsuji T, Ichinose M. Hepatic Encephalopathy with Status Epileptics: A Case Report. World J Gastroenterol 2006;12:1793-4.
[24] Eleftheriadis N, Fourla E, Eleftheriadis D. Status Epilepticus as a Manifestation of Hepatic Encephalopathy. Acta Neurol Scand 2003;107:142-4.
[25] Newey CR, George P, Sarwal A, So N, Hantus S. ElectroRadiological Observations of Grade III/IV Hepatic Encephalopathy Patients with Seizures. Neurocrit Care 2018;28:97-103.
[26] Jo YM, Lee SW, Han SY, Baek YH, Ahn JH, Choi WJ, et al. Nonconvulsive Status Epilepticus Disguising as Hepatic Encephalopathy. World J Gastroenterol 2015;21:5105-9.
[27] Amodio P, Pellegrini A, Ubiali E, Mathy I, Piccolo FD, Orsato R, et al. The EEG Assessment of Low-Grade Hepatic Encephalopathy: Comparison of an Artificial Neural Network-Expert System (ANNES) Based Evaluation with Visual EEG Readings and EEG Spectral Analysis. Clin Neurophysiol 2006;117:2243-51.
[28] Montagnese S, DeRui M, Schiff S, Ceranto E, Valenti P, Angeli P, et al. Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD Score: The MELD-EEG. Liver Int 2015;35:58-64.
[29] Wszolek ZK, Aksamit AJ, Ellingson RJ, Sharbrough FW, Westmoreland BF, Pfeiffer RF, et al. Epileptiform Encephalographic Abnormalities in Liver Transplant Recipients. Ann Neurol 1991;30:37-41.
[30] Sutter R, Stevens RD, Kaplan PW. Significance of Triphasic Waves in Patients with Acute Encephalopathy: A NineYear Cohort Study. Clin Neurophysiol 2013;124:1952-8.
[31] Tapper, EB, Aberasturi, D, Zhao, Z, Hsu, CY, Parikh, ND. Outcomes after Hepatic Encephalopathy in PopulationBased Cohorts of Patients with Cirrhosis. Aliment Pharmacol Ther 2020;51:1397-405.
[32] Ezaz G, Murphy SL, Mellinger J, Tapper EB. Increased Morbidity and Mortality Associated with Falls among Patients with Cirrhosis. Am J Med 2018;131:645-50.
[33] Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic Significance of Hepatic Encephalopathy in Patients with Cirrhosis. J Hepatol 1999;30:890-5.
[34] Montagnese S, de Rui M, Schiff S, Ceranto E, Valenti P, Angeli P, et al. Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD Score: The MELD-EEG. Liver Int 2015;35:58-64.
[35] Dasgupta A, Debbarma A, Choudhury SK. Evaluation of the Role of Electroencephalography in the Early Diagnosis of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver. J Evid Based Med Healthc 2019;6:2945-9.
[36] Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, et al. Spectral Versus Visual EEG Analysis in Mild Hepatic Encephalopathy. Clin Neurophysiol 1999;110:1334-44.
[37] Amodio P, Del Piccolo F, Petteno E, Mapelli D, Angeli P, Iemmolo R, et al. Prevalence and Prognostic Value of Quantified Electroencephalogram (EEG) Alterations in Cirrhotic Patients. J Hepatol 2001;35:37-45.
[38] Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, et al. Neurophysiological Investigations of Hepatic Encephalopathy: ISHEN Practice Guidelines. Liver Int 2009;29:789-96.
[39] Sagalés T, Gimeno V, de la Calzada MD, Casellas F, MaciàMD, Soriano MV. Brain Mapping Analysis in Patients with Hepatic Encephalopathy. Brain Topogr 1990;2:221-8.
[40] Kullmann F, Hollerbach S, Lock G, Holstege A, Dierks T, Schölmerich J. Brain electrical Activity Mapping of EEG for the Diagnosis of (Sub)clinical Hepatic Encephalopathy in Chronic Liver Disease. Eur J Gastroenterol Hepatol 2001;13:513-22.
[41] Kubota Y, Nakamoto H, Egawa S, Kawamata T. Continuous EEG Monitoring in ICU. J Intensive Care 2018;6:39.
[42] Abend NS, Dlugos DJ, Hahn CD, Hirsch LJ, Herman ST. Use of EEG monitoring and Management of NonConvulsive Seizures in Critically Ill Patients: A Survey of Neurologists. Neurocrit Care 2010;12:382-9.